Abstract
A 35 year old black Somalian woman with miliary tuberculosis developed hepatotoxicity after a few days of treatment with isoniazid, rifampicin, pyrazinamide, and ethambutol. After withdrawal of all drugs the liver profile returned to normal and remained so after challenge with isoniazid. Hepatotoxicity recurred when rifampicin was added, but it was well tolerated when reintroduced without isoniazid.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kopanoff D. E., Snider D. E., Jr, Caras G. J. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis. 1978 Jun;117(6):991–1001. doi: 10.1164/arrd.1978.117.6.991. [DOI] [PubMed] [Google Scholar]
- Kopanoff D. E., Snider D. E., Jr, Caras G. J. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis. 1978 Jun;117(6):991–1001. doi: 10.1164/arrd.1978.117.6.991. [DOI] [PubMed] [Google Scholar]
- Lees A. W., Allan G. W., Smith J., Tyrrell W. F., Fallon R. J. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy. Tubercle. 1971 Sep;52(3):182–190. doi: 10.1016/0041-3879(71)90041-9. [DOI] [PubMed] [Google Scholar]
- Lewis J. H., Zimmerman H. J. Drug-induced liver disease. Med Clin North Am. 1989 Jul;73(4):775–792. doi: 10.1016/s0025-7125(16)30638-1. [DOI] [PubMed] [Google Scholar]
- Sarma G. R., Immanuel C., Kailasam S., Narayana A. S., Venkatesan P. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin. Am Rev Respir Dis. 1986 Jun;133(6):1072–1075. doi: 10.1164/arrd.1986.133.6.1072. [DOI] [PubMed] [Google Scholar]
- Steele M. A., Burk R. F., DesPrez R. M. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest. 1991 Feb;99(2):465–471. doi: 10.1378/chest.99.2.465. [DOI] [PubMed] [Google Scholar]